
Pear Therapeutics, Inc. – NASDAQ:PEAR
Pear Therapeutics stock price monthly change
Pear Therapeutics stock price quarterly change
Pear Therapeutics stock price yearly change
Pear Therapeutics key metrics
Market Cap | 4.08M |
Enterprise value | N/A |
P/E | -0.22 |
EV/Sales | -1.21 |
EV/EBITDA | 0.16 |
Price/Sales | 0.82 |
Price/Book | 0.50 |
PEG ratio | 0.01 |
EPS | 0.16 |
Revenue | 12.69M |
EBITDA | -169.39M |
Income | 24.77M |
Revenue Q/Q | -39.04% |
Revenue Y/Y | 201.66% |
Profit margin | -501% |
Oper. margin | -1018.74% |
Gross margin | 35.62% |
EBIT margin | -1018.74% |
EBITDA margin | -1334.48% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePear Therapeutics stock price history
Pear Therapeutics stock forecast
Pear Therapeutics financial statements
Mar 2022 | 2.74M | -12.97M | -472.06% |
---|---|---|---|
Jun 2022 | 3.29M | 43.74M | 1326.78% |
Sep 2022 | 4.08M | -34.81M | -852.73% |
Dec 2022 | 2.56M | 28.82M | 1123.86% |
Mar 2022 | 172092000 | 102.58M | 59.61% |
---|---|---|---|
Jun 2022 | 142519000 | 63.47M | 44.54% |
Sep 2022 | 119735000 | 67.48M | 56.37% |
Dec 2022 | 95129000 | 64.54M | 67.85% |
Mar 2022 | -36.70M | -43.5M | 75K |
---|---|---|---|
Jun 2022 | -29.63M | -307K | 761K |
Sep 2022 | -23.27M | 22.42M | 358K |
Dec 2022 | -24.28M | 11.93M | 961K |
Pear Therapeutics alternative data
Aug 2023 | 200 |
---|---|
Sep 2023 | 200 |
Oct 2023 | 200 |
Nov 2023 | 200 |
Dec 2023 | 200 |
Jan 2024 | 200 |
Feb 2024 | 200 |
Mar 2024 | 200 |
Apr 2024 | 200 |
May 2024 | 200 |
Jun 2024 | 200 |
Jul 2024 | 200 |
Pear Therapeutics other data
Period | Buy | Sel |
---|---|---|
Aug 2022 | 0 | 400000 |
Sep 2022 | 0 | 1328168 |
Oct 2022 | 0 | 42164 |
Nov 2022 | 0 | 117326 |
Jan 2023 | 0 | 115096 |
Apr 2023 | 0 | 3707624 |
Quarter | Transcript |
---|---|
Q3 2022 14 Nov 2022 | Q3 2022 Earnings Call Transcript |
Q2 2022 14 Aug 2022 | Q2 2022 Earnings Call Transcript |
Q1 2022 17 May 2022 | Q1 2022 Earnings Call Transcript |
Q4 2021 28 Mar 2022 | Q4 2021 Earnings Call Transcript |
Pear Therapeutics Lays Off 9% Of Workforce, Guides For $15 Million Revenue
Pear Therapeutics Sees Growing Fulfillment Rates And Payor Traction
Pear Therapeutics Guiding For Being 1% Down The Potential Runway In Current Markets
Even With Low Penetration Assumptions For PDTs, Pear Therapeutics Is A Buy
-
When is Pear Therapeutics's next earnings date?
Unfortunately, Pear Therapeutics's (PEAR) next earnings date is currently unknown.
-
Does Pear Therapeutics pay dividends?
No, Pear Therapeutics does not pay dividends.
-
How much money does Pear Therapeutics make?
Pear Therapeutics has a market capitalization of 4.08M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 201.66% to 12.69M US dollars.
-
What is Pear Therapeutics's stock symbol?
Pear Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "PEAR".
-
What is Pear Therapeutics's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Pear Therapeutics?
Shares of Pear Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Pear Therapeutics have?
As Jul 2024, Pear Therapeutics employs 200 workers.
-
When Pear Therapeutics went public?
Pear Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 31 Mar 2021.
-
What is Pear Therapeutics's official website?
The official website for Pear Therapeutics is peartherapeutics.com.
-
Where are Pear Therapeutics's headquarters?
Pear Therapeutics is headquartered at 200 State Street, Boston, MA.
-
How can i contact Pear Therapeutics?
Pear Therapeutics's mailing address is 200 State Street, Boston, MA and company can be reached via phone at +61 79257848.
Pear Therapeutics company profile:

Pear Therapeutics, Inc.
peartherapeutics.comNASDAQ
200
Medical - Healthcare Information Services
Healthcare
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
Boston, MA 02109
CIK: 0001835567
ISIN: US7047231052
CUSIP: 704723105